| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 9 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | Canada | 2 | |
| #4 | EPO (European Patent Office) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Machines | |
| #3 | Measurement | |
| #4 | Biotechnology | |
| #5 | Organic fine chemistry | |
| #6 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Analysing materials | |
| #5 | Unspecified technologies | |
| #6 | Sugars | |
| #7 | Unspecified technologies | |
| #8 | Animal care |
| # | Name | Total Patents |
|---|---|---|
| #1 | Averback Paul | 17 |
| #2 | Gemmell Jack | 7 |
| #3 | Focht Ma Soledad S | 1 |
| #4 | Fitzpatrick Judith | 1 |
| #5 | Bibiano Riza | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2008027005A1 | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells | |
| US2005226883A1 | Humanized antibody | |
| WO9516917A1 | Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto | |
| US5231170A | Antibodies to dense microspheres | |
| US4919915A | Method for detecting the ability to prevent red-to-green congophilic birefringence | |
| US4816416A | Microspheric bodies for use in screening therapies for Azheimer's disease and related conditions |